Clostridium perfringens in central Colombia: frequency, toxin genes, and risk factors.
Clostridium perfringens
Asymptomatic
Risk factors
Symptomatic
Toxins
Journal
Gut pathogens
ISSN: 1757-4749
Titre abrégé: Gut Pathog
Pays: England
ID NLM: 101474263
Informations de publication
Date de publication:
04 Jul 2024
04 Jul 2024
Historique:
received:
29
01
2024
accepted:
28
06
2024
medline:
5
7
2024
pubmed:
5
7
2024
entrez:
4
7
2024
Statut:
epublish
Résumé
Clostridium perfringens is an opportunistic bacterium that causes intestinal diseases in both humans and animals. This study aimed to assess the frequency of C. perfringens and the presence of toxin-encoding genes in fecal samples from individuals with or without gastrointestinal symptoms in the Department of Boyacá, Colombia. Additionally, risk factors associated with carriage and disease development were analyzed. A total of 114 stool samples were analyzed using a molecular test based on specific polymerase chain reaction (PCR) targeting 16S-rRNA and alpha toxin (cpa) genes. For individuals with a positive result for the PCR test, stool samples were cultured on Tryptose Sulfite Cycloserine (TSC) agar. Two to five colonies forming units were selected based on phenotypic characteristics, resulting in 56 bacterial isolates. These isolates were then analyzed for toxin-coding genes associated with gastrointestinal diseases. In addition, sociodemographic and clinical data from 77 individuals were also analyzed. The overall frequency of C. perfringens was 19.3% (n = 22/114). The detection frequency in 77 individuals with clinical data was 16.6% (n = 5/30) among symptomatic individuals and 21.2% (n = 10/47) among asymptomatic individuals. All 56 isolates obtained carried the cpa gene, while cpb2 was present in 10.7% (n = 6/56); cpe and cpb genes were not detected. Notably, diabetes and autoimmune diseases are significantly associated with an increased risk of C. perfringens detection (adjusted OR 8.41: 95% CI 1.32-35.89). This study highlights an elevated frequency of C. perfringens and the presence of the cpb2 gene in asymptomatic individuals compared with their symptomatic counterparts. These findings offer insights into the distribution and virulence factors of C. perfringens at a micro-geographical level. This information supports the need for developing tailored prevention strategies based on local characteristics to promote active surveillance programs based on molecular epidemiology.
Identifiants
pubmed: 38965598
doi: 10.1186/s13099-024-00629-5
pii: 10.1186/s13099-024-00629-5
doi:
Types de publication
Journal Article
Langues
eng
Pagination
32Subventions
Organisme : Ministerio de Ciencia Tecnología e Innovación (Minciencias)
ID : code: 722289684653 contract No. 613-2021
Informations de copyright
© 2024. The Author(s).
Références
Asha N, Tompkins D, Wilcox MH. Comparative analysis of prevalence, risk factors, and molecular epidemiology of antibiotic-associated diarrhea due to Clostridium difficile Clostridium perfringens, and Staphylococcus aureus. J Clin Microbiol. 2006;44(8):2785–91. https://doi.org/10.1128/JCM.00165-06.
doi: 10.1128/JCM.00165-06.
pubmed: 16891493
pmcid: 1594656
Kyne L, Merry C, O’Connell B, Kelly A, Keane C, O’Neill D, et al. Factors associated with prolonged symptoms and severe disease due to Clostridium difficile. Age Ageing. 1999;28(2):107–13. https://doi.org/10.1093/ageing/28.2.107 .
doi: 10.1093/ageing/28.2.107
pubmed: 10350405
Casadevall A, Pirofski LA. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Immunity. 2000;68(12):6511–8. https://doi.org/10.1128/IAI.68.12.6511-6518.2000.
doi: 10.1128/IAI.68.12.6511-6518.2000.
Larcombe S, Hutton ML, Lyras D. Involvement of bacteria other than Clostridium difficile in antibiotic-associated diarrhoea. Trends Microbiol. 2016;24(6):463–76. https://doi.org/10.1016/j.tim.2016.02.001 .
doi: 10.1016/j.tim.2016.02.001
pubmed: 26897710
Uzal FA, Freedman JC, Shrestha A, Theoret JR, Garcia J, Awad MM, et al. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 2014;9(3):361–77. https://doi.org/10.2217/fmb.13.168 .
doi: 10.2217/fmb.13.168
pubmed: 24762309
Kiu R, Hall LJ. An update on the human and animal enteric pathogen Clostridium perfringens. Emer Microbes Infect. 2018;7(1):1–15. https://doi.org/10.1038/s41426-018-0144-8.
doi: 10.1038/s41426-018-0144-8.
Vaishnavi C, Kaur S. Clostridium perfringens enterotoxin in antibiotic-associated diarrhea. Microbiology. 2008;51(2):198. https://doi.org/10.4103/0377-4929.41681 .
doi: 10.4103/0377-4929.41681
Azimirad M, Gholami F, Yadegar A, Knight DR, Shamloei S, Aghdaei HA, et al. Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran. Sci Rep. 2019;9(1):7792. https://doi.org/10.1038/s41598-019-44281-5.
doi: 10.1038/s41598-019-44281-5.
pubmed: 31127185
pmcid: 6534674
Grass JE, Gould LH, Mahon BE. Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens United States. Disease. 2013;10(2):131–6. https://doi.org/10.1089/fpd.2012.1316 .
doi: 10.1089/fpd.2012.1316
Dewey-Mattia D, Manikonda K, Hall AJ, Wise ME, Crowe SJ. Surveillance for foodborne disease outbreaks—United States, 2009–2015. MMWR Surveill Summ. 2018. https://doi.org/10.15585/mmwr.ss6710a1 .
doi: 10.15585/mmwr.ss6710a1
pubmed: 30048426
pmcid: 6061962
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, et al. Foodborne illness acquired in the United States—major pathogens. Emerg Infect Dis. 2011;17(1):7–15. https://doi.org/10.3201/eid1701.p11101 .
doi: 10.3201/eid1701.p11101
pubmed: 21192848
pmcid: 3375761
Forero AJ, Muñoz M, Camargo M, Soto-De León SC, Ríos-Chaparro DI, Birchenall C, et al. High frequency of toxigenic Clostridium difficile and Clostridium perfringens coinfection among diarrheic patients at health care facility-onset (HCFO) and community-onset (CO) centers in Bogotá. Colombia. 2019;11:1–6. https://doi.org/10.1186/s13099-019-0308-7.
doi: 10.1186/s13099-019-0308-7.
Roussan D, Shaheen IA, Totanji W, Khawaldeh G, Al Rifai RH. Simultaneous detection of Clostridium perfringens and Clostridium colinum by duplex-polymerase chain reaction. Poultry Sci. 2012;91(12):3080–5. https://doi.org/10.3382/ps.2012-02368 .
doi: 10.3382/ps.2012-02368
Kotsanas D, Carson JA, Awad MM, Lyras D, Rood JI, Jenkin GA, et al. Novel use of tryptose sulfite cycloserine egg yolk agar for isolation of Clostridium perfringens during an outbreak of necrotizing enterocolitis in a neonatal unit. J clin microbiol. 2010;48(11):4263–5. https://doi.org/10.1128/JCM.01724-10 .
doi: 10.1128/JCM.01724-10
pubmed: 20826643
pmcid: 3020804
Baums CG, Schotte U, Amtsberg G, Goethe R. Diagnostic multiplex PCR for toxin genotyping of Clostridium perfringens isolates. Veterinary Microbiol. 2004;100(1–2):11–6. https://doi.org/10.1016/S0378-1135(03)00126-3 .
doi: 10.1016/S0378-1135(03)00126-3
Kutner MH, Nachtsheim CJ, Neter J, Li W. Applied linear statistical models. New York: McGraw-hill; 2005.
Chatterjee S, Hadi AS. Regression analysis by example. Hoboken: John Wiley & Sons; 2013.
Carey J, Cole J, Venkata SLG, Hoyt H, Mingle L, Nicholas D, et al. Determination of genomic epidemiology of historical Clostridium perfringens outbreaks in New York State by use of two web-based platforms: national center for biotechnology information pathogen detection and FDA GalaxyTrakr. J Clin Microbiol. 2021;59(2):e02200-e2220. https://doi.org/10.1128/JCM.02200-20.
doi: 10.1128/JCM.02200-20.
pubmed: 33177125
pmcid: 8111140
Abrahao C, Carman R, Hahn H, Liesenfeld O, Diseases I. Similar frequency of detection of Clostridium perfringens enterotoxin and Clostridium difficile toxins in patients with antibiotic-associated Diarrhea. Eur J Clin Microbiol Infect Dis. 2001;20(9):676. https://doi.org/10.1007/s100960100571 .
doi: 10.1007/s100960100571
pubmed: 11714055
Joshy L, Chaudhry R, Dhawan B, Kumar L, Das BK. Incidence and characterization of Clostridium perfringens isolated from antibiotic-associated diarrhoeal patients: a prospective study in an Indian hospital. J Hospital Infect. 2006;63(3):323–9. https://doi.org/10.1016/j.jhin.2005.12.015 .
doi: 10.1016/j.jhin.2005.12.015
Wang B, Dong W, Ma L, Dong Y, Wang S, Yuan Y, et al. Prevalence and genetic diversity of Clostridium perfringens isolates in hospitalized diarrheal patients from Central China. Infec Drug Res. 2021. https://doi.org/10.2147/IDR.S338593 .
doi: 10.2147/IDR.S338593
Carman RJ, Sayeed S, Li J, Genheimer CW, Hiltonsmith MF, Wilkins TD, et al. Clostridium perfringens toxin genotypes in the feces of healthy North Americans. Anaerobe. 2008;14(2):102–8. https://doi.org/10.1016/j.anaerobe.2008.01.003 .
doi: 10.1016/j.anaerobe.2008.01.003
pubmed: 18353695
pmcid: 2444017
Vela M, Heredia NL, Feng P. DNA probe analysis for the carriage of enterotoxigenic Clostridium perfringens in feces of a Mexican subpopulation. Garcı́a-Alvarado J. 1999;35(2):101–4. https://doi.org/10.1016/s0732-8893(99)00058-9 .
doi: 10.1016/s0732-8893(99)00058-9
Flores J, Okhuysen PC. Genetics of susceptibility to infection with enteric pathogens. Cur Opin Infect Dis. 2009;22(5):471. https://doi.org/10.1097/QCO.0b013e3283304eb6.
doi: 10.1097/QCO.0b013e3283304eb6.
Kim Y, Lee K, Ryu S. A survey of human serum samples for antibody against Clostridium perfringens type a enterotoxin in humans in Korea. Int J Food Microbiol. 1998;41(3):239–41. https://doi.org/10.1016/s0168-1605(98)00053-1 .
doi: 10.1016/s0168-1605(98)00053-1
pubmed: 9706792
Shrestha A, Uzal FA, McClane BA. Enterotoxic clostridia: Clostridium perfringens enteric diseases. Microbiol Spectr. 2018. https://doi.org/10.1128/microbiolspec.GPP3-0003-2017 .
doi: 10.1128/microbiolspec.GPP3-0003-2017
pubmed: 30238869
Johnson S. Antibody responses to clostridial infection in humans. Clin Infect Dis. 1997;25(Suppl 2):S173–7. https://doi.org/10.1086/516220 .
doi: 10.1086/516220
pubmed: 9310668
Valgaeren B, Pardon B, Goossens E, Verherstraeten S, Schauvliege S, Timbermont L, et al. lesion development in a new intestinal loop model indicates the involvement of a shared Clostridium perfringens virulence factor in haemorrhagic enteritis in calves. J Comp Pathol. 2013;149(1):103–12. https://doi.org/10.1016/j.jcpa.2012.11.237 .
doi: 10.1016/j.jcpa.2012.11.237
pubmed: 23351504
Furuya-Kanamori L, Marquess J, Yakob L, Riley TV, Paterson DL, Foster NF, et al. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect Dis. 2015;15(1):516. https://doi.org/10.1186/s12879-015-1258-4.
doi: 10.1186/s12879-015-1258-4.
pubmed: 26573915
pmcid: 4647607
Nakano V, Ignacio A, Llanco L, Bueris V, Sircili MP, Avila-Campos MJ. Multilocus sequence typing analyses of Clostridium perfringens type a strains harboring tpeL and netB genes. Anaerobe. 2017;44:99–105. https://doi.org/10.1016/j.anaerobe.2017.02.017 .
doi: 10.1016/j.anaerobe.2017.02.017
pubmed: 28238845
Lee H, Lee S, Kim S, Lee J, Ha J, Choi Y, et al. Asymptomatic Clostridium perfringens inhabitation in intestine can cause inflammation, apoptosis, and disorders in brain. Foodborne Pathogens Dis. 2020;17(1):52–65. https://doi.org/10.1089/fpd.2019.2677 .
doi: 10.1089/fpd.2019.2677
Hmood AM, Al-Shukri MS, Al-Charrakh AH. Molecular detection and antimicrobial resistance of Clostridium perfringens isolated from diabetic patients and bullet wounds. Biotechnology. 2019;7(1):54–9. https://doi.org/10.7324/JABB.2019.70110 .
doi: 10.7324/JABB.2019.70110
Sanz N, Ruiz-Bastian M, Barros C, Gomez-Garces JL. Bacteriemia por Clostridium perfringens Un análisis de 28 casos durante 10 años en un hospital universitario de Madrid. Enfermedades Infecciosas y Microbiol Clínica. 2018;36(4):225–8. https://doi.org/10.1016/j.eimc.2017.02.002 .
doi: 10.1016/j.eimc.2017.02.002
Serafio-Gómez JL, Bustillos-Ponce M, Almeida-Muñoz DE, Parra-Hernández JA, Pompa-Díaz JC. Unbridled threat of gas gangrene in a patient with uncontrolled diabetes mellitus: a compelling case report of Clostridium perfringens infection. Cureus. 2023;15(12): e50614. https://doi.org/10.7759/cureus.50614 .
doi: 10.7759/cureus.50614
pubmed: 38111817
pmcid: 10726074
Severin WP, de la Fuente AA, Stringer MF. Clostridium perfringens type C causing necrotising enteritis. J Clin Pathol. 1984;37(8):942–4. https://doi.org/10.1136/jcp.37.8.942 .
doi: 10.1136/jcp.37.8.942
pubmed: 6088590
pmcid: 498895
Gui L, Subramony C, Fratkin J, Hughson MD. Fatal enteritis necroticans (pigbel) in a diabetic adult. Modern pathol. 2002;15(1):66–70. https://doi.org/10.1038/modpathol.3880491 .
doi: 10.1038/modpathol.3880491
Matsuda T, Okada Y, Inagi E, Tanabe Y, Shimizu Y, Nagashima K, et al. Enteritis necroticans “pigbel” in a Japanese diabetic adult. Pathol Int. 2007;57(9):622–6. https://doi.org/10.1111/j.1440-1827.2007.02149.x .
doi: 10.1111/j.1440-1827.2007.02149.x
pubmed: 17685936
Benz R, Piselli C, Hoxha C, Koy C, Glocker MO, Popoff MR. Clostridium perfringens Beta2 toxin forms highly cation-selective channels in lipid bilayers. Eur Biophys J. 2022;51(1):15–27. https://doi.org/10.1007/s00249-021-01577-7 .
doi: 10.1007/s00249-021-01577-7
pubmed: 34854958
Bellavia A, Rotem RS, Dickerson AS, Hansen J, Gredal O, Weisskopf MG. The use of logic regression in epidemiologic studies to investigate multiple binary exposures: an example of occupation history and amyotrophic lateral sclerosis. Epidemiol Methods. 2020. https://doi.org/10.1515/em-2019-0032 .
doi: 10.1515/em-2019-0032
pubmed: 33224709
pmcid: 7679079
Shipe ME, Deppen SA, Farjah F, Grogan EL. Developing prediction models for clinical use using logistic regression: an overview. J Thorac Dis. 2019;11(Suppl 4):S574–84. https://doi.org/10.21037/jtd.2019.01.25.
doi: 10.21037/jtd.2019.01.25.
pubmed: 31032076
pmcid: 6465431
Sperandei S. Understanding logistic regression analysis. Biochemia Medica. 2014;24(1):12–8. https://doi.org/10.11613/BM.2014.003.
doi: 10.11613/BM.2014.003.
pubmed: 24627710
pmcid: 3936971
Nagendra L, Boro H, Mannar VJE. Bacterial infections in diabetes. 2022. MDText.com, Inc.; 2000.
Frydrych LM, Fattahi F, He K, Ward PA, Delano MJ. Diabetes and sepsis: risk, recurrence, and ruination. Front Endocrinol. 2017;8:271. https://doi.org/10.3389/fendo.2017.00271 .
doi: 10.3389/fendo.2017.00271
Flores-Diiaz M, Alape-Giron A, Titball RW, Moos M, Guillouard I, Cole S, et al. UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C. J Biol Chem. 1998. https://doi.org/10.1074/jbc.273.38.24433 .
doi: 10.1074/jbc.273.38.24433
Gui L, Subramony C, Fratkin J, Hughson MD. Fatal enteritis necroticans (Pigbel) in a diabetic adult. Mod Pathol. 2002;15(1):66–70. https://doi.org/10.1038/modpathol.3880491 .
doi: 10.1038/modpathol.3880491
pubmed: 11796843
Francis MB, Allen CA, Shrestha R, Sorg JA. Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog. 2013;9(5): e1003356. https://doi.org/10.1371/journal.ppat.1003356 .
doi: 10.1371/journal.ppat.1003356
pubmed: 23675301
pmcid: 3649964
Hoonakker M, Zariri A, de Brouwer L, David D, Borgman A, Sloots A. An in vitro assay for toxicity testing of Clostridium perfringens type C β-toxin. Front Immunol. 2024;15:1373411. https://doi.org/10.3389/fimmu.2024.1373411 .
doi: 10.3389/fimmu.2024.1373411
pubmed: 38646535
pmcid: 11026656
Herrera G, Vega L, Camargo A, Patarroyo MA, Ramírez JD, Muñoz M. Acquisition site-based remodelling of Clostridium perfringens- and Clostridioides difficile-related gut microbiota. Comp Immunol Microbiol Infect Dis. 2023;102: 102074. https://doi.org/10.1016/j.cimid.2023.102074 .
doi: 10.1016/j.cimid.2023.102074
pubmed: 37832162
El Kadri H, Alaizoki A, Celen T, Smith M, Onyeaka H. The effect of low-temperature long-time (LTLT) cooking on survival of potentially pathogenic Clostridium perfringens in beef. Int J Food Microbiol. 2020;320: 108540. https://doi.org/10.1016/j.bbadis.2024.167108 .
doi: 10.1016/j.bbadis.2024.167108
pubmed: 32044624